🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.120
-0.060 (-2.75%)
At close: Nov 19, 2026, 4:00 PM EST
2.125
+0.005 (0.24%)
After-hours: Nov 19, 2026, 7:39 PM EST

Minerva Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cost of Revenue
---12.71--
Gross Profit
----12.71--
Selling, General & Admin
15.369.349.9510.4110.5813.33
Research & Development
19.775.7611.9-14.6516.84
Operating Expenses
35.1315.121.8510.4125.2330.17
Operating Income
-35.13-15.1-21.85-23.12-25.23-30.17
Interest Expense
---4.56-8.28-7.41-6.33
Interest & Investment Income
2.330.951.271.440.560.02
Currency Exchange Gain (Loss)
-0.05-0.06-0-0.04-0.03-0.03
Other Non Operating Income (Expenses)
-251.42-279.2126.58---
EBT Excluding Unusual Items
-284.26-293.421.44-30.01-32.11-36.51
Asset Writedown
------15.2
Pretax Income
-290.86-293.421.44-30.01-32.11-51.71
Income Tax Expense
------1.8
Net Income
-290.86-293.421.44-30.01-32.11-49.91
Net Income to Common
-290.86-293.421.44-30.01-32.11-49.91
Net Income Growth
------
Shares Outstanding (Basic)
3888755
Shares Outstanding (Diluted)
3888755
Shares Change
398.74%11.75%16.41%21.84%-4.41%
EPS (Basic)
-7.70-34.670.19-4.61-6.01-9.35
EPS (Diluted)
-8.44-34.670.19-4.61-6.01-9.35
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-31.4-13.51-19.55-14.78-24.66-24.6
Free Cash Flow Per Share
-0.83-1.60-2.58-2.27-4.62-4.61
EBITDA
-35.12-15.1-21.84-23.11--30.15
D&A For EBITDA
0.010.010.010.01-0.02
EBIT
-35.13-15.1-21.85-23.12-25.23-30.17
SEC Filings: 10-K · 10-Q